Name | Number of supported studies | Average coverage | |
---|---|---|---|
regulatory T cell | 5 studies | 20% ± 4% | |
epithelial cell | 4 studies | 24% ± 8% | |
basal cell | 4 studies | 28% ± 18% | |
endothelial cell | 3 studies | 29% ± 19% | |
fibroblast | 3 studies | 18% ± 2% | |
CD4-positive, alpha-beta T cell | 3 studies | 17% ± 3% | |
transit amplifying cell | 3 studies | 44% ± 25% | |
microglial cell | 3 studies | 20% ± 3% |
Insufficient scRNA-seq data for expression of DDB2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
uterus | 100% | 2233.40 | 170 / 170 | 99% | 34.65 | 455 / 459 |
bladder | 100% | 1745.14 | 21 / 21 | 99% | 23.74 | 499 / 504 |
lung | 99% | 1841.17 | 575 / 578 | 99% | 21.42 | 1148 / 1155 |
skin | 100% | 3718.18 | 1809 / 1809 | 99% | 28.53 | 466 / 472 |
breast | 100% | 1859.88 | 459 / 459 | 99% | 19.86 | 1103 / 1118 |
thymus | 99% | 1100.72 | 647 / 653 | 99% | 26.02 | 600 / 605 |
intestine | 100% | 1896.47 | 966 / 966 | 98% | 16.85 | 516 / 527 |
esophagus | 100% | 1988.17 | 1445 / 1445 | 98% | 16.95 | 179 / 183 |
prostate | 100% | 2146.44 | 244 / 245 | 98% | 14.04 | 491 / 502 |
adrenal gland | 100% | 2876.80 | 258 / 258 | 97% | 20.79 | 223 / 230 |
kidney | 98% | 803.80 | 87 / 89 | 99% | 34.29 | 888 / 901 |
stomach | 97% | 1118.40 | 349 / 359 | 99% | 15.30 | 283 / 286 |
pancreas | 96% | 1238.60 | 316 / 328 | 99% | 18.93 | 177 / 178 |
ovary | 100% | 1448.17 | 180 / 180 | 96% | 11.99 | 411 / 430 |
liver | 99% | 1209.76 | 223 / 226 | 97% | 17.38 | 393 / 406 |
brain | 61% | 391.89 | 1609 / 2642 | 97% | 15.49 | 687 / 705 |
eye | 0% | 0 | 0 / 0 | 100% | 31.47 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 40.25 | 29 / 29 |
spleen | 100% | 2284.10 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 46.27 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 21.86 | 1 / 1 |
adipose | 100% | 1690.21 | 1202 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 2037.71 | 1327 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 92% | 2116.89 | 852 / 929 | 0% | 0 | 0 / 0 |
heart | 87% | 610.32 | 745 / 861 | 0% | 0 | 0 / 0 |
muscle | 70% | 449.57 | 565 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006281 | Biological process | DNA repair |
GO_0000209 | Biological process | protein polyubiquitination |
GO_0034644 | Biological process | cellular response to UV |
GO_0006289 | Biological process | nucleotide-excision repair |
GO_0070914 | Biological process | UV-damage excision repair |
GO_0006974 | Biological process | DNA damage response |
GO_0051865 | Biological process | protein autoubiquitination |
GO_0009411 | Biological process | response to UV |
GO_0006290 | Biological process | pyrimidine dimer repair |
GO_0031464 | Cellular component | Cul4A-RING E3 ubiquitin ligase complex |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0080008 | Cellular component | Cul4-RING E3 ubiquitin ligase complex |
GO_0090734 | Cellular component | site of DNA damage |
GO_0031465 | Cellular component | Cul4B-RING E3 ubiquitin ligase complex |
GO_0030054 | Cellular component | cell junction |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
GO_0005515 | Molecular function | protein binding |
GO_0003684 | Molecular function | damaged DNA binding |
Gene name | DDB2 |
Protein name | Damage-specific DNA-binding protein 2 DNA damage-binding protein 2 (DDB p48 subunit) (DDBb) (Damage-specific DNA-binding protein 2) (UV-damaged DNA-binding protein 2) (UV-DDB 2) Damage specific DNA binding protein 2 |
Synonyms | |
Description | FUNCTION: Protein, which is both involved in DNA repair and protein ubiquitination, as part of the UV-DDB complex and DCX (DDB1-CUL4-X-box) complexes, respectively . Core component of the UV-DDB complex (UV-damaged DNA-binding protein complex), a complex that recognizes UV-induced DNA damage and recruit proteins of the nucleotide excision repair pathway (the NER pathway) to initiate DNA repair . The UV-DDB complex preferentially binds to cyclobutane pyrimidine dimers (CPD), 6-4 photoproducts (6-4 PP), apurinic sites and short mismatches . Also functions as the substrate recognition module for the DCX (DDB2-CUL4-X-box) E3 ubiquitin-protein ligase complex DDB2-CUL4-ROC1 (also known as CUL4-DDB-ROC1 and CUL4-DDB-RBX1) . The DDB2-CUL4-ROC1 complex may ubiquitinate histone H2A, histone H3 and histone H4 at sites of UV-induced DNA damage . The ubiquitination of histones may facilitate their removal from the nucleosome and promote subsequent DNA repair . The DDB2-CUL4-ROC1 complex also ubiquitinates XPC, which may enhance DNA-binding by XPC and promote NER . The DDB2-CUL4-ROC1 complex also ubiquitinates KAT7/HBO1 in response to DNA damage, leading to its degradation: recognizes KAT7/HBO1 following phosphorylation by ATR . .; FUNCTION: [Isoform D1]: Inhibits UV-damaged DNA repair. .; FUNCTION: [Isoform D2]: Inhibits UV-damaged DNA repair. . |
Accessions | ENST00000378600.7 [Q92466-2] A0A087X0X5 ENST00000622090.4 ENST00000378603.7 [Q92466-4] Q92466 ENST00000256996.9 [Q92466-1] A0A087WTQ7 A0A087WV56 ENST00000614825.4 A0A087WYT8 ENST00000378601.7 [Q92466-5] A0A087WW71 ENST00000616278.4 [Q92466-3] ENST00000617847.4 ENST00000610805.4 ENST00000622878.4 |